Variable | Total N = 400 | No aTRH N = 325 | aTRH N = 75 | p-value | Uncontrolled aTRH N = 44 | Controlled aTRH N = 31 | p-value |
---|---|---|---|---|---|---|---|
Demographics | Â | Â | Â | Â | Â | Â | Â |
Age (years) mean(± SD) | 64.4 (10.8) | 64.2(10.7) | 65.4(11.1) | 0.383 | 63.5(11.5) | 68.1(10.0) | 0.074 |
Age category, n (%) | Â | Â | Â | Â | Â | Â | Â |
30–39 | 4 (1.0) | 4 (1.2) | 0 (0) | 1.00 | 0(0) | 0(0) |  |
40–49 | 30 (7.5) | 22(6.8) | 8(10.7) | 0.248 | 6(13.6) | 2(6.5) | 0.457 |
50–59 | 94 (23.5) | 78 (24.0) | 16(21.3) | 0.623 | 10(22.7) | 6(19.4) | 0.782 |
60–69 | 139 (34.8) | 117 (36.0) | 22(29.3) | 0.274 | 13(29.5) | 9(29.0) | 0.962 |
70–79 | 100(25.0) | 79 (24.3) | 21(28.0) | 0.506 | 11(25.0) | 10(32.3) | 0.475 |
80–89 | 32(8.0) | 25 (7.7) | 7(9.3) | 0.637 | 4(9.1) | 3(9.7) | 0.931 |
90–99 | 1(0.3) | 0 (0) | 1(1.3) | 0.187 | 0(0) | 1(3.2) | 0.230 |
Gender n (%) | Â | Â | Â | Â | Â | Â | Â |
Female | 260(65.0) | 213(65.5) | 47(62.7) | 0.638 | 30(68.2) | 17(54.8) | 0.239 |
Ethnicity, n (%) | Â | Â | Â | Â | Â | Â | Â |
Caucasian | 54(13.5) | 46(14.2) | 8(10.7) | 0.426 | 3(6.8) | 5(16.1) | 0.263 |
Black African | 143(35.8) | 104(32.0) | 39(52.0) | < 0.001 | 26(59.1) | 13(41.9) | 0.143 |
Mixed | 81(20.3) | 69(21.2) | 12(16.0) | 0.310 | 4(9.1) | 8(25.8) | 0.063 |
Indian | 122(30.5) | 106(32.6) | 16(21.3) | 0.056 | 11(25.0) | 5(16.1) | 0.405 |
Family history of hypertension in first-degree relative n (%) | 286(71.5) | 229(70.5) | 57(76.0) | 0.338 | 35(79.6) | 22(71.0) | 0.392 |
Family history of premature cardiovascular disease in first-degree relative n (%) | 106(26.5) | 81(24.9) | 25(33.3) | 0.137 | 16(36.4) | 9(29.0) | 0.507 |
Health behaviours | Â | Â | Â | Â | Â | Â | Â |
% Adherence (MARS-5), median ± IQR | 96(12) | 96(12) | 96(4) | < 0.001 | 96(4) | 96(4) | 0.875 |
Smoking status | Â | Â | Â | Â | Â | Â | Â |
Current smoker | 52(13.0) | 41(12.6) | 11(14.7) | 0.634 | 6(13.6) | 5(16.1) | 0.754 |
Past smoker | 105(26.3) | 91(28.0) | 14(18.6) | 0.098 | 5(11.4) | 9(29.0) | 0.073 |
Never smoker | 243(60.8) | 193(59.4) | 50(66.7) | 0.244 | 33(75.0) | 17(54.8) | 0.068 |
Excess alcohol consumption n (%) | Â | Â | Â | Â | Â | Â | Â |
Yes | 80(20.0) | 64(19.7) | 16(21.3) | 0.749 | 8(18.2) | 8(25.8) | 0.568 |
Dietary salt reduction n (%) | Â | Â | Â | Â | Â | Â | Â |
Yes | 93(23.3) | 76(23.4) | 17(22.6) | 0.397 | 11(25.0) | 6(19.3) | 0.843 |
Physical activity | Â | Â | Â | Â | Â | Â | Â |
1–3 times a week | 122(30.5) | 104(32.0) | 18(24.0) | 0.175 | 11(25.0) | 7(22.6) | 0.389 |
3–5 times a week | 27(6.8) | 22(6.8) | 5(6.7) | 0.975 | 3(6.8) | 2(6.5) | 0.998 |
> 5 times a week | 2(0.5) | 2(0.6) | 0(0) | 0.496 | 0(0) | 0(0) | 0.793 |
None | 249(62.3) | 197(60.6) | 52(69.3) | 0.160 | 30(68.2) | 22(71.0) | 0.362 |
Anthropometric measurements | Â | Â | Â | Â | Â | Â | Â |
Body mass index (BMI) kg/m2, Median (IQR) | 31.19 (8.2) | 29.93(7.8) | 32.89(10.3) | < 0.001 | 34.5(21.5) | 30.5(6.5) | 0.0386 |
BMI Categories, n (%) | Â | Â | Â | Â | Â | Â | Â |
Underweight | 4(1.0) | 4(1.2) | 0(0) | 0.334 | 0(0) | 0(0) | Â |
Normal | 67(16.8) | 62(19.1) | 5(6.7) | 0.009 | 3(6.8) | 2(6.5) | 0.950 |
Overweight | 118(29.5) | 96(29.5) | 22(29.3) | 0.972 | 9(20.5) | 13(41.9) | 0.044 |
Obese Class I | 117(29.3) | 97(29.9) | 20(26.7) | 0.585 | 11(25.0) | 9(29.0) | 0.697 |
Obese Class II | 56(14.0) | 44(13.5) | 12(16.0) | 0.580 | 9(20.5) | 3(9.7) | 0.338 |
Obese Class III | 38(9.5) | 22(6.8) | 16(21.3) | < 0.001 | 12(27.2) | 4(12.9) | 0.162 |
Waist circumference (cm), median (IQR) | 99.3(18.8) | 97.6(18.0) | 106.5(17.4) | < 0.001 | 108.2(18.3) | 102.4(14.7) | 0.064 |
Blood pressure parameters | Â | Â | Â | Â | Â | Â | Â |
Systolic BP (mmHg), median (IQR) | 138.0(21.7) | 137.0(20.3) | 146.3(25.0) | 0.003 | 151.2(13.3) | 126.7(10.6) | < 0.001 |
Diastolic BP (mmHg), mean (± SD) | 76.1(10.4) | 75.8(10.2) | 77.2(11.4) | 0.315 | 81.5(11.8) | 70.9(7.2) | < 0.001 |
Pulse pressure mean (± SD) | 61.0(19.5) | 59.6(18.4) | 67.3(21.7) | 0.013 | 73.2(11.1) | 55.7(9.9) | < 0.001 |
Blood pressure control, n (%) | Â | Â | Â | Â | Â | Â | Â |
Controlled | 235(58.75) | Â | Â | Â | Â | Â | Â |
Uncontrolled | 165(41.25) | Â | Â | Â | Â | Â | Â |
aTRH prevalence, n (%) | 75(18.8) | Â | Â | Â | 44(11.0) | 31(7.8) | Â |
Pseudo-resistance | Â | Â | Â | Â | Â | Â | Â |
Non-adherence | 76(19.0) | Â | Â | Â | Â | Â | Â |
Under-treatment | 4(1.0) | Â | Â | Â | Â | Â | Â |